Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Johnson & Johnson

Capitalization 582B 508B 459B 439B 799B 53,806B 831B 5,488B 2,175B 25,706B 2,183B 2,137B 92,846B P/E ratio 2026 *
25.6x
P/E ratio 2027 * 23.7x
Enterprise value 600B 524B 474B 453B 824B 55,469B 857B 5,658B 2,242B 26,501B 2,250B 2,203B 95,716B EV / Sales 2026 *
5.96x
EV / Sales 2027 * 5.53x
Free-Float
77.08%
Yield 2026 *
2.19%
Yield 2027 * 2.32%
1 day-1.13%
1 week+0.47%
Current month-2.78%
1 month-0.79%
3 months+14.15%
6 months+35.64%
Current year+16.70%
1 week 240.04
Extreme 240.04
245.59
1 month 235.43
Extreme 235.43
251.71
Current year 200.91
Extreme 200.9101
251.71
1 year 141.5
Extreme 141.5
251.71
3 years 140.68
Extreme 140.68
251.71
5 years 140.68
Extreme 140.68
251.71
10 years 106.36
Extreme 106.36
251.71
Manager TitleAgeSince
Chief Executive Officer 63 03/01/2022
Director of Finance/CFO 59 01/07/2018
Chief Tech/Sci/R&D Officer 61 01/08/2024
Director TitleAgeSince
Director/Board Member 62 15/10/2013
Director/Board Member 71 09/06/2015
Chairman 63 02/01/2023
Change 5d. change 1-year change 3-years change Capi.($)
-0.21%+0.47%+48.18%+57.79% 582B
+0.80%-0.53%+22.88%+203.58% 880B
-2.52%-4.53%+3.84%+44.57% 388B
+0.79%-6.01%+5.81%+21.36% 324B
+0.11%-0.83%+21.02%+34.57% 295B
+0.43%-1.54%+25.20%+62.42% 293B
-0.26%-0.16%+22.07%+9.34% 286B
-0.43%-0.90%+17.13%+57.05% 197B
+0.42%+0.74%+27.91%+82.35% 180B
+0.02%-0.34%-52.94%-49.79% 168B
Average -0.26%-1.36%+14.11%+52.33% 359.42B
Weighted average by Cap. -0.36%-1.32%+19.74%+79.55%

Financials

2026 *2027 *
Net sales 101B 87.93B 79.44B 75.99B 138B 9,304B 144B 949B 376B 4,445B 377B 369B 16,054B 106B 92.83B 83.86B 80.23B 146B 9,823B 152B 1,002B 397B 4,693B 399B 390B 16,949B
Net income 22.24B 19.44B 17.56B 16.8B 30.56B 2,057B 31.77B 210B 83.15B 983B 83.46B 81.7B 3,550B 23.93B 20.92B 18.9B 18.08B 32.89B 2,214B 34.18B 226B 89.48B 1,058B 89.81B 87.91B 3,820B
Net Debt 17.99B 15.72B 14.2B 13.59B 24.71B 1,664B 25.69B 170B 67.25B 795B 67.5B 66.07B 2,871B 6.06B 5.3B 4.79B 4.58B 8.33B 561B 8.66B 57.18B 22.66B 268B 22.74B 22.26B 967B
Logo Johnson & Johnson
Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (64.1%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (35.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; At the end of 2025, Johnson & Johnson has 63 manufacturing facilities located in the United States (22), North America (7), Europe (22), Africa and Asia/Pacific (12). The United States accounts for 57.1% of net sales.
Employees
138,200
Date Price Change Volume
13/03/26 241.52 $ -0.21% 6,415,539
12/03/26 242.04 $ -0.39% 7,710,152
11/03/26 242.99 $ -0.30% 6,934,842
10/03/26 243.71 $ +0.46% 7,214,122
09/03/26 242.59 $ +0.91% 7,844,028
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
241.52USD
Average target price
238.29USD
Spread / Average Target
-1.34%

Quarterly revenue - Rate of surprise

SPRING SALE - 40%: The Best Tools Reserved for Subscribers to Identify Tomorrow's Top Investments!
d
:
:
BENEFIT NOW